Allelic variant in the glucagon-like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study

Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study

(2015) Mojca Jensterle et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Quantitative Gastrointestinal and Psychological Traits Associated With Obesity and Response to Weight-Loss Therapy

(2015) Andres Acosta et al.   GASTROENTEROLOGY

GLP-1 stimulates insulin secretion by PKC-dependent TRPM4 and TRPM5 activation

(2015) Makoto Shigeto et al.   JOURNAL OF CLINICAL INVESTIGATION

Evaluation of weight loss and metabolic changes in diabetic patients treated with liraglutide, effect of RS 6923761 gene variant of glucagon-like peptide 1 receptor

(2015) Daniel Antonio de Luis et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

(2015) Xavier Pi-Sunyer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of a high-protein/low-carbohydrate versus a standard hypocaloric diet on adipocytokine levels and cardiovascular risk factors during 9 months, role of rs6923761 gene variant of glucagon-like peptide 1 receptor

(2015) D. A. de Luis et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Effect of rs6923761 gene variant of glucagon-like peptide 1 receptor on metabolic response and weight loss after a 3-month intervention with a hypocaloric diet

(2014) Daniel Antonio de Luis et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Gastric emptying, mouth-to-cecum transit, and glycemic, insulin, incretin, and energy intake responses to a mixed-nutrient liquid in lean, overweight, and obese males

(2012) Radhika V. Seimon et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants

(2012) M. CAMILLERI et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Association of TCF7L2 Allelic Variations with Gastric Function, Satiation, and GLP-1 Levels

(2011) Maria I. Vazquez-Roque et al.   CTS-Clinical and Translational Science

Gestational diabetes mellitus is associated with TCF7L2 gene polymorphisms independent of HLA-DQB1*0602 genotypes and islet cell autoantibodies

(2011) A. Papadopoulou et al.   DIABETIC MEDICINE

Comment on: Villareal et al. (2009) TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action. Diabetes;59:479-485

(2010) F. K. Knop   DIABETES

Common Genetic Variation in GLP1R and Insulin Secretion in Response to Exogenous GLP-1 in Nondiabetic Subjects: A pilot study

(2010) A. Sathananthan et al.   DIABETES CARE

TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action

(2009) D. T. Villareal et al.   DIABETES

The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men

(2009) K. Pilgaard et al.   DIABETOLOGIA

Endogenous Glucagon-Like Peptide-1 Slows Gastric Emptying in Healthy Subjects, Attenuating Postprandial Glycemia

(2009) Adam M. Deane et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM